These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11517646)

  • 1. Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.
    Bungard TJ; Ghali WA; McAlister FA; Buchan AM; Cave AJ; Hamilton PG; Mitchell LB; Shuaib A; Teo KK; Tsuyuki RT
    CMAJ; 2001 Aug; 165(3):301-2. PubMed ID: 11517646
    [No Abstract]   [Full Text] [Related]  

  • 2. The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.
    Bungard TJ; Ghali WA; McAlister FA; Buchan AM; Cave AJ; Hamilton PG; Mitchell LB; Shuaib A; Teo KK; Tsuyuki RT
    Can J Cardiol; 2003 Mar; 19(3):280-4. PubMed ID: 12677283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
    Morgan SV
    Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835
    [No Abstract]   [Full Text] [Related]  

  • 4. Bleeding risk on warfarin among elderly patients with atrial fibrillation.
    Cowan A; Hylek EM
    J Am Coll Cardiol; 2010 Mar; 55(9):932; author reply 932-3. PubMed ID: 20185052
    [No Abstract]   [Full Text] [Related]  

  • 5. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 6. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.
    Kutner M; Nixon G; Silverstone F
    Arch Intern Med; 1991 Oct; 151(10):1950-3. PubMed ID: 1929682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 10. Stroke in heart failure: atrial fibrillation revisited?
    Pullicino P; Homma S
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):1-2. PubMed ID: 20123219
    [No Abstract]   [Full Text] [Related]  

  • 11. Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tay KH; Lip GY; Lane DA
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):392-3. PubMed ID: 19542940
    [No Abstract]   [Full Text] [Related]  

  • 12. Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors.
    Lane DA; Lip GY
    Stroke; 2008 Jan; 39(1):7-9. PubMed ID: 18048849
    [No Abstract]   [Full Text] [Related]  

  • 13. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
    Nagarakanti R; Ezekowitz MD; Oldgren J; Yang S; Chernick M; Aikens TH; Flaker G; Brugada J; Kamensky G; Parekh A; Reilly PA; Yusuf S; Connolly SJ
    Circulation; 2011 Jan; 123(2):131-6. PubMed ID: 21200007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians.
    Gattellari M; Worthington J; Zwar N; Middleton S
    Stroke; 2008 Jan; 39(1):227-30. PubMed ID: 18048861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?
    Karthikeyan G; Eikelboom JW
    Thromb Haemost; 2010 Jul; 104(1):45-8. PubMed ID: 20458437
    [No Abstract]   [Full Text] [Related]  

  • 18. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE; Lake JD
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study.
    Devereaux PJ; Anderson DR; Gardner MJ; Putnam W; Flowerdew GJ; Brownell BF; Nagpal S; Cox JL
    BMJ; 2001 Nov; 323(7323):1218-22. PubMed ID: 11719412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of thromboembolic events in atrial fibrillation.
    Koefoed BG; Gulløv AL; Petersen P
    Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.